Restart Life Sciences (HN30) Stock Forecast & Price Target
HN30 Analyst Ratings
There are no analyst ratings in the last 3 months.
HN30 Stock 12 Month Forecast
There are no analyst price targets in the last 3 months.
Detailed List of Analyst Forecasts
Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| PerPlexity - SonarReasoningPro | TipRanks - PerPlexity | EUR 0.05→EUR 0.04 | sell | -4.87%Downside | Downgraded | 10/30/26 | ||
| Google Biotechnology | TipRanks - Google | EUR 0.04→EUR 0.04 | sell | -3.31%Downside | Reiterated | 10/30/26 | ||
| Anthropic Biotechnology | TipRanks - Anthropic | EUR 0.04→EUR 0.04 | sell | -4.87%Downside | Reiterated | 10/30/26 | ||
| OpenAI - Gpt-5.6Sol | TipRanks - OpenAI | EUR 0.04→EUR 0.04 | hold | -3.31%Downside | Upgraded | 10/30/26 | ||
| DeepSeek - V4Pro | TipRanks - DeepSeek | EUR 0.04→EUR 0.04 | sell | -4.87%Downside | Downgraded | 10/30/26 | ||
| xAI - Grok-4.3 | TipRanks - xAI | EUR 0.05→EUR 0.04 | sell | -4.87%Downside | Reiterated | 10/30/26 |
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| PerPlexity - SonarReasoningPro | 10/30/26 | EUR 0.05→EUR 0.04 | sell | -4.87%Downside | Downgraded | TipRanks - PerPlexity | ||
| Google Biotechnology | 10/30/26 | EUR 0.04→EUR 0.04 | sell | -3.31%Downside | Reiterated | TipRanks - Google | ||
| Anthropic Biotechnology | 10/30/26 | EUR 0.04→EUR 0.04 | sell | -4.87%Downside | Reiterated | TipRanks - Anthropic | ||
| OpenAI - Gpt-5.6Sol | 10/30/26 | EUR 0.04→EUR 0.04 | hold | -3.31%Downside | Upgraded | TipRanks - OpenAI | ||
| DeepSeek - V4Pro | 10/30/26 | EUR 0.04→EUR 0.04 | sell | -4.87%Downside | Downgraded | TipRanks - DeepSeek | ||
| xAI - Grok-4.3 | 10/30/26 | EUR 0.05→EUR 0.04 | sell | -4.87%Downside | Reiterated | TipRanks - xAI |
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
HN30 Analyst Recommendation Trends
| Rating | May 26 | Jun 26 | Jul 26 | Aug 26 | Sep 26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 0 | 0 | 0 | 0 | 0 |
In the current month, HN30 has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. HN30 average Analyst price target in the past 3 months is ―.
HN30 Financial Forecast
ConsensusEUR -0.01
HN30 Earnings Forecast
Next quarter’s earnings estimate for HN30 is -EUR 0.01 with a range of ― to ―. The previous quarter’s EPS was -EUR 0.01. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
ConsensusEUR 205K
HN30 Sales Forecast
Next quarter’s sales forecast for HN30 is EUR 205.48K with a range of ― to ―. The previous quarter’s sales results were EUR 205.48K. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.
HN30 Stock Forecast FAQ
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
What do analysts say about Restart Life Sciences?
Not enough analysts have published a price target to provide an average price target.
How can I buy shares of Restart Life Sciences?
To buy shares of DE:HN30, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.